Relationship between reduced serum IGF-I levels and accumulation of visceral fat in Japanese men

被引:47
作者
Kunitomi, M
Wada, J
Takahashi, K
Tsuchiyama, Y
Mimura, Y
Hida, K
Miyatake, N
Fujii, M
Kira, S
Shikata, K
Makino, H
机构
[1] Okayama Univ, Sch Med, Dept Med 3, Okayama 7008558, Japan
[2] Okayama Univ, Fac Educ, Okayama, Japan
[3] Okayama So Inst Hlth, Okayama, Japan
[4] Okayama Univ, Sch Med, Dept Publ Hlth, Okayama 700, Japan
关键词
insulin-like growth factor-I (IGF-I); visceral fat; exercise;
D O I
10.1038/sj.ijo.0801899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To investigate whether the changes in IGF-1 concentrations after weight reduction in Japanese overweight men are associated with changes in visceral and subcutaneous fat. DESIGN: Cross-sectional and longitudinal clinical intervention study with exercise education. SUBJECTS: One-hundred and twelve Japanese overweight men aged 30-59y (body mass index (BMI) 28.4+/-2.5 kg/m(2)) and 33 normal-weight men aged 30-39y (BMI 22.1+/-1.5 kg/m(2)) at baseline. From the participants, 56 randomly selected overweight men (BMI 28.8+/-2.8) were further enrolled into a 1 y exercise program. MEASUREMENTS: Fat distribution was evaluated by visceral fat M and subcutaneous fat (S) areas measured with computed tomography scanning at umbilical levels, metabolic parameters and hormones including insulin, leptin and IGF-1 at baseline and after 1 y. RESULTS: In 112 overweight subjects at baseline, insulin (10.5+/-5.0 muUl/ml) and leptin (6.4+/-3.7 ng/ml) significantly correlated with both V (r=0.260, P=0.0073; r=0.410, P<0.0001) and S areas (r=0.377, P<0.0001; r=0.613, P<0.0001), respectively. IGF-1 (156.8+/-48.7 muU/ml) significantly and negatively correlated with V area (r= -0.242, P=0.0125)and age (r= - 0.192, P=0.0480). In normal-weight men aged 30-39y (n=33) and age-matched subjects (n=30) selected from the 112 overweight men, the serum IGF-1 further tightly correlated with V area (r= - 0.467, P<0.0001). Visceral fat area and age were independently related to serum IGF-1 levels by multiple regression analysis. By intervention with exercise education, 56 overweight subjects showed an increase in daily steps (6224+/-2781 to 7898+/-4141 steps/day) and reduction of BMI (28.8+/-2.8 to 27.7+/-2.9). DeltaIGF-1 significantly correlated with DeltaV area (r= - 0.432, P = 0.0009) but not with DeltaS area or DeltaBMI. CONCLUSION: The present study indicated a negative correlation between IGF-1 levels and visceral fat at baseline as well as an association between the reduction in visceral fat and increase in IGF-1 levels after an exercise intervention.
引用
收藏
页码:361 / 369
页数:9
相关论文
共 39 条
  • [1] Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: Effect of short- and long-term weight reduction
    Argente, J
    Caballo, N
    Barrios, V
    Pozo, J
    Munoz, MT
    Chowen, JA
    Hernandez, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) : 2076 - 2083
  • [2] Visceral adiposity and risk of type 2 diabetes - A prospective study among Japanese Americans
    Boyko, EJ
    Fujimoto, WY
    Leonetti, DL
    Newell-Morris, L
    [J]. DIABETES CARE, 2000, 23 (04) : 465 - 471
  • [3] Regulation of in vivo growth hormone secretion by leptin.
    Carro, E
    Senaris, R
    Considine, RV
    Casanueva, FF
    Dieguez, C
    [J]. ENDOCRINOLOGY, 1997, 138 (05) : 2203 - 2206
  • [4] RELATIONS BETWEEN IMMUNOREACTIVE SOMATOMEDIN-C, INSULIN AND T3 PATTERNS DURING FASTING IN OBESE SUBJECTS
    CAUFRIEZ, A
    GOLSTEIN, J
    LEBRUN, P
    HERCHUELZ, A
    FURLANETTO, R
    COPINSCHI, G
    [J]. CLINICAL ENDOCRINOLOGY, 1984, 20 (01) : 65 - 70
  • [5] COPELAND KC, 1990, METABOLISM, V41, P106
  • [6] Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin
    Fernandez-Real, JM
    Granada, ML
    Ruzafa, A
    Casamitjana, R
    Ricart, W
    [J]. CLINICAL ENDOCRINOLOGY, 2000, 52 (02) : 159 - 164
  • [7] Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy
    Florkowski, CM
    Crozier, IG
    Nightingale, S
    Evans, MJ
    Ellis, MJ
    Joyce, P
    Donald, RA
    [J]. CLINICAL ENDOCRINOLOGY, 1996, 44 (02) : 163 - 168
  • [8] FREE INSULIN-LIKE GROWTH-FACTORS IN HUMAN OBESITY
    FRYSTYK, J
    VESTBO, E
    SKJAERBAEK, C
    MOGENSEN, CE
    ORSKOV, H
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (10): : 37 - 44
  • [9] Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.3.CO
  • [10] 2-5